Delivery Order SPE2DE21D7010-SPE2D626F90M6
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,969.84 delivery order by the Defense Logistics Agency Medical Supply Chain on December 11, 2025, for MODULUS spinal surgical products. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, indicating open market competition. Performance will be completed at Nuvasive's San Diego facility by December...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $22,128.07 on November 25, 2025, for the supply of MODULUS spinal surgical products and related medical devices. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by January 2, 2026, with performance conducted at Nuvasive's San Diego, California facility. The contract was issued without set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting successful competition in an open market procurement. The award is scheduled for completion by January 2, 2026, with...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order contract valued at $7,358.52 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025, with a completion date of October 24, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment mechanisms and covers the supply of the MODULUS spinal surgical product to support federal healthcare operations. This award...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $43,480.80 fixed-price delivery order with economic price adjustment provisions by the Defense Logistics Agency Medical Supply Chain on October 28, 2025, with an ultimate completion date of November 18, 2025. The award is designated as an M5 delivery order issued without set-aside restrictions, indicating competition in an open market procurement. Performance will be...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $5,477.02 on December 4, 2025, for the MODULUS spinal surgical product through the Defense Logistics Agency (DLA) Medical Supply Chain. This fixed-price contract with economic price adjustment provisions is scheduled for completion by December 31, 2025, with performance occurring at Nuvasive's San Diego facility. The award carries no set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., received a delivery order award valued at $8,138.78 from the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of January 2, 2026. This fixed-price delivery order with economic price adjustment pricing will be fulfilled at Nuvasive's San Diego facility and involves the supply of LEVERAGE LFS spinal medical devices and related surgical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,956.60 on December 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and involves the supply of MAXCESS spinal surgical products and related medical devices to support federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order (Contract No. 4570300073) valued at $2,009.60 by the Defense Logistics Agency Medical Supply Chain on December 12, 2025. The contract covers the delivery of MAXCESS spinal surgical products and related medical devices to support Department of Defense and Department of Veterans Affairs healthcare operations. Structured as a firm...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $5,204.05 on November 14, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is for the supply of LEVERAGE LFS spinal medical devices and related surgical instruments, with performance to be completed by December 5, 2025, at Nuvasive's...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F90M6Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $11,287.94 delivery order (Contract No. 4570435995) by the Defense Logistics Agency Medical Supply Chain on December 31, 2025, with completion targeted for January 2, 2026. The contract utilizes a fixed-price structure with economic price adjustment mechanisms and involves the delivery of MODULUS spinal surgical products and related medical technologies to support federal healthcare operations. Performance will occur at Nuvasive's San Diego, California facility. This award was issued without set-aside restrictions, demonstrating the company's competitive standing in open market procurements serving the Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order is issued against Transplant Technology Inc.'s broader $8 million Blanket Purchase Agreement with the Defense Health Agency, structured as an Indefinite Delivery/Indefinite Quantity contract vehicle effective through March 2027, which streamlines procurement of Nuvasive's comprehensive spinal fusion devices, implants, surgical instruments, and bone graft materials across military and veteran healthcare facilities. The award reflects the ongoing demand for specialized orthopedic and neurosurgical technologies supporting complex surgical procedures within the federal healthcare enterprise, with Nuvasive serving as a critical supplier to multiple federal agencies including the Defense Health Agency, Department of Veterans Affairs, and Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 12/30/25 |